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Abstract
Blood transfusions are contributing to a higher rate of hepatitis C virus (HCV) in Pakistan. Half of all blood 
transfusions in Pakistan are not screened for hepatitis C, hepatitis B or HIV. Family members donate blood 
that is likely not tested due to social stigma attached to HCV. Paid donations are also quite common in the 
country, especially by people who inject drugs (PWID), which increases the population’s exposure to HCV. 
Most of the population utilizes the private sector for their health needs; this sector has lax regulation due to 
the lack of oversight by the government or any other regulatory body. In addition, groups who are at most 
need for blood transfusions, such as hemophiliacs and those with thalassemia, have a higher rate of hepatitis 
C. This fact reinforces the need for blood transfusion reform in Pakistan, which includes improving oversight, 
upgrading infrastructure and promoting health literacy through cultural norms, according to the World Health 
Organization (WHO) recommendations. The lessons learned in Pakistan can be adapted to countries facing 
similar issues.
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While some bloodborne diseases such as HIV/AIDS have been given serious attention in Pakistan, hepatitis C virus (HCV) has received inadequate 
effort and still remains a serious public health issue. There 
are 240 0001 new HCV cases in the country yearly and these 
have been attributed largely to medical procedures,2 even the 
death of renowned devotional singer Nusrat Fateh Ali Khan 
was blamed on infected medical equipment that caused him 
to contract HCV.3 Blood transfusion practices in particular 
are now being found to contribute to a high rate of hepatitis 
C in Pakistan; transfusions which are meant to save lives, are 
now putting people at a greater risk of exposure to HCV. In a 
developing country like Pakistan, unsafe blood transfusions 
could cause a serious socioeconomic impact in the long 
run and it is not the only nation that is facing this concern. 
Examining the case of Pakistan would be relevant to other 
countries dealing with similar structural and cultural barriers 
in order to overcome blood transfusion safety obstacles, and 
to prevent the outbreak of other potential epidemics, such as 
HIV and hepatitis B virus (HBV).
It has been estimated that up to 40% of transfused blood in 
Pakistan is not screened for any communicable diseases in 
general.4 Particularly, about half of blood transfusions are not 
screened for hepatitis C, hepatitis B or HIV.5 These statistics 
are concerning, especially when considering the high level of 
hepatitis C infections among those who receive regular blood 
transfusions. In fact, the percentage of hepatitis C among 
patients with thalassemia and hemophilia is estimated to 
be as high as 56% and 20%, respectively.6 The patients who 
are infected with these diseases must often receive regular 
transfusions as a part of therapy, which makes their high HCV 
rates particularly relevant. Compounding this is another 
study of patients with hepatitis C; over 48% of these patients 
had a history of blood transfusions in the past 6 months as the 
main risk factor for HCV.7 It is worth considering that an even 
greater number of people could be infected through the reuse 
of syringes or use of blood belonging to the initially infected 
recipients. Therefore, given these facts it is very important 
to investigate the contributing elements of hazardous blood 
transfusions. 
The World Health Organization (WHO) has laid out 
guidelines to ensure that blood transfusions are performed in 
a safe, sanitary manner.8 Pakistan is dealing with challenges in 
several of these categories, such as implementing a policy on 
blood screening that defines national requirements, screening 
all blood donations for a variety of infections including HCV, 
adequate resources being made available for screening, properly 
training enough staff and regulatory systems being established to 
oversee all public and private blood transfusions, among others 
which may explain its high rate of HCV infection through 
blood transfusions. There are three main areas of concern in 
the country, which pertain to oversight, infrastructure and 
culture.
Pakistan has been seen to have an inadequate system 
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of oversight, especially in the medical field.9 In fact, it’s 
national health ministry was dissolved for a number of 
years, preventing the formulation of a decisive countrywide 
health plan. The regulation of the entire medical sector is 
very lax, and devolution of healthcare responsibilities to 
the provincial governments have made implementation 
of reforms ever more difficult.10 National guidelines on the 
clinical use of blood were established in 1999 but have not 
been implemented to date,11 though most government clinics 
do attempt to screen for hepatitis C and B, and HIV.12 The 
healthcare system of Pakistan consists of a public three tiered 
system; at the federal, provincial and district levels. The 
federal government is responsible for policy development, 
provincial governments must provide healthcare services, 
and district governments are responsible for actual service 
delivery through primary and secondary health facilities.13 
The aforementioned devolution in the healthcare sector has 
given more responsibility for improved service delivery to 
district facilities. These health facilities are meant to be free 
for the public, but they may suffer from mismanagement or a 
lack of resources14; in fact only 1% of national gross domestic 
product (GDP) is spent on healthcare by the government, one 
of the lowest in the region.15 This decreases their effectiveness 
in providing effective services. Therefore, much of the 
population opts to use the private sector for its health care 
needs, which provides upwards of 70% of the healthcare 
provision in Pakistan.16 Contrary to the government clinics, 
the private sector sees little regulation and many of its medical 
procedures go unregistered.
The blood transfusion system in Pakistan lacks uniformity 
and consists of 1830 blood centers, of which 85% are private 
entities or non-governmental organizations (NGOs) and 
many of the rest are public clinics.11 The system sees very low 
rates of voluntary blood donation; only about 13% of blood 
donations in the country come from voluntary donations, 
with much of the rest being obtained from other sources, 
such as family donations.17 There are estimated to be around 
1.5 million documented blood transfusions in Pakistan 
yearly, with many patients receiving multiple transfusions.18 
The number of undocumented blood transfusions could be 
far greater due to the informal nature of the Pakistani health 
system, which means enforcing regulations to maintain the 
integrity of transfusions is a challenge. This is a serious problem 
given the gaps that are present in the surveillance system for 
transfusions, and that as much as a third of blood donors have 
hepatitis C.19 Paid blood donations can also be complicit in 
the spread of HCV when there is a lack of proper screening; 
one study found that 31% of blood transfusion transactions 
used blood from paid donors.20 Many people who inject drugs 
(PWID) sell blood to earn a living and considering that as 
much as 94% of the PWID population in parts of Pakistan 
may be infected with HCV, this is particularly concerning. 
Exacerbating this concern is the possibility that many of these 
transfusions may go untested.21
The lack of infrastructure and scarcity of human resources 
also affect the safety of blood transfusions. For instance in 
Larkana, a district dealing with many HCV cases, there is a 
shortage of doctors who are HCV specialists, and clinics in 
the area lack adequate blood banking practices.22 Although 
Larkana is relatively undeveloped, there is little to suggest 
that the situation in more developed parts of the country is 
significantly different. As of 2013, there was no governmental 
body to regulate blood transfusions in even the most 
developed province in the country, Punjab.8 Blood centers 
across the country lack temperature monitored equipment to 
store test kits properly, and more than half of blood centers 
lack an internal quality audit system or even an algorithm that 
screens for transfusion transmissible infections.23 Difficulties 
such as the lack of a dependable power supply also prevent 
clinics from using the proper equipment to maintain hygiene 
during transfusions, or from keeping donated blood at the 
proper temperature.8
In addition to structural barriers, there are cultural barriers. 
There is still a certain stigma attached to being HCV positive; 
it often affects marriages, relationships with family and 
may even cause depression among patients.24 Consequently, 
people are not willing to talk about HCV, brushing it under 
the rug instead. Complicating this issue even further is the 
fact that blood is often donated to patients from relatives, who 
are unwilling to state their hepatitis C status due to the fear of 
being shamed, or of losing a family member due to the lack 
of blood.25
The government of Pakistan attempted to address the hepatitis 
C epidemic through the Prime Minister’s Program for the 
prevention and control of hepatitis viral infection.26 This was 
an unsuccessful 5-year program that ended in 2010; there 
were a few thousand patients who were treated for hepatitis 
infections, but with poor follow up and little systemic change 
its effectiveness was stymied. There was no effort to put in 
the necessary infrastructure to enforce regulations and 
blood transfusion safety. After this, there has been a call for 
institutional and legislative reform in the Pakistani health 
sector, but little has changed.10 
With an epidemic of this scale, treatment of the multitude 
of infected is difficult, so the cure must be prevention. 
Among many steps, at least four should be prioritized to 
reduce the prevalence of this disease: (1) To create a national 
taskforce that implements the National Guidelines for blood 
transfusions that were established; (2) Alleviate infrastructural 
issues by providing clinics with proper equipment (ie, testing 
algorithms, generators) to ensure a sanitary environment for 
blood transfusions and by training adequate medical staff in 
HCV prevention and blood transfusion safety; (3) Document 
and monitor clinics (public and private) across the country 
to ensure compliance with blood screening policies; (4) Use 
media and cultural outlets to spread awareness about safe 
transfusions and recruit voluntary blood donors to ensure 
a safe and continuous blood donor pool. Implementing 
these strategies in Pakistan would allow policymakers in 
order to have a better understanding of how more effective 
approaches to overcome blood transfusion safety barriers 
can be developed. The lessons that are learned can then be 
adapted to prevent the spread of other diseases, such as HIV.
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